Author

Maura Gillison

The University of Texas MD Anderson Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Alexandre ReubeniD· 1 shared Amanda MontoyaiD· 1 shared Anika PateliD· 1 shared Benjamin H. HinrichsiD· 1 shared Bin Zhang· 1 shared Bo JiangiD· 1 shared Changsheng XingiD· 1 shared Dalia El-GamaliD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexandre ReubenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

HER2 mutation-derived neoantigens in NSCLC as actionable targets for TCR therapy

Amanda Montoya, Hui Nie, Peixin Jiang, Jared K. Slone, Yulia V. Shulga, Anika Patel, Prashant S. Menon, Isabella Polic, Emily Bontekoe, Lingzhi Hong, Minying Zhang, Emane Rose Assita, Sarah Forward, Changsheng Xing, Bo Jiang, , Alexandre Reuben

The paper identifies TCRs targeting HER2 mutations in NSCLC, showing they recognize mutant epitopes and maintain cytotoxic activity, offering a potential immunotherapy strategy.

bioRxiv · Aug 4, 2026 · PreprintImmunology

Genome-Wide Variations of End Motif in Cell-Free DNA Fragments Distinguish Immunotherapy Responders from Non-Responders in Head and Neck Cancer: A Multi-Institute Prospective Study

Ravi Bandaru, Hailu Fu, Haizi Zheng, Jocelyn Liang, Li Wang, Shuchi Gulati, Benjamin H. Hinrichs, Mingxiang Teng, Bin Zhang, Marsha Kocherginsky, Dechen Lin, David A. Hildeman, Francis Paul Worden, Matthew Owen Old, Neal Dunlap, , Yaping Liu

This study identifies a novel cfDNA fragmentomic metric, rMDS, that distinguishes immunotherapy responders from non-responders in HNSCC with high accuracy.

medRxiv · Mar 30, 2026 · PreprintGenetic & Genomic Medicine